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Abstract
Chimeric antigen receptor T cell therapy has demonstrated innovative therapeutic
effectiveness in fighting cancers; however, it is extremely expensive due to the intrinsic
patient-to-patient variability in cell manufacturing. We propose in this work a novel
calibration-free statistical framework to effectively recover critical quality attributes
under the patient-to-patient variability. Specifically, we model this variability via a
patient-specific calibration parameter, and use readings from multiple biosensors to
construct a patient-invariance statistic, thereby alleviating the effect of the calibration
parameter. A carefully formulated optimization problem and an algorithmic framework
are presented to find the best patient-invariance statistic and the model parameters.
Using the patient-invariance statistic, we can recover the critical quality attribute
of interest, free from the calibration parameter. We demonstrate improvements of
the proposed calibration-free method in different simulation experiments. In the
cell manufacturing case study, our method not only effectively recovers viable cell
concentration for monitoring, but also reveals insights for the cell manufacturing
process.
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1 Introduction
Cell therapy is one of the most promising new treatment approaches over the last decades,
demonstrating great potential in treating cancers, including leukemia and lymphoma (Kim
and De Vellis, 2009; Yin, 2017). Among those therapies, chimeric antigen receptor (CAR)
T cell therapy (Bonifant et al., 2016; June et al., 2018), involving the reprogramming
of a patients T cells to effectively target and attack tumor cells, has shown innovative
therapeutic effects in clinical trials, leading to a recent approval (i.e., the treatment of CD19+
hematological malignancies, see Prasad, 2018) by FDA as a new cancer treatment modality.
As illustrated in Figure 1, a typical CAR T cell therapy involves four steps – deriving cells
from a patient, genetically modifying the cells, culturing the cells, and re-administering
back to the patient. With increasingly mature gene modification technology, more and more
researchers focus on the culturing step (i.e., the red box in Figure 1), where the goal is to
substantially increase the cell amount from a small batch to one dose for delivery to the
patient. However, a key challenge is the intrinsic patient-to-patient variability in the starting
material, i.e., cells derived from different patients vary in their viabilities, acceptance rates
of genetic modification, and reactions to culture media (Hinrichs and Restifo, 2013). These
variabilities introduce difficulties in cell culturing scale-up (i.e., cell manufacturing), and
therefore, the current CAR T cell therapy is hindered by low scalability, labor-intensive
processes, and extremely high cost (Harrison et al., 2019). To achieve high quality and
acceptable vein-to-vein cost, we present in this work a statistical framework for online
monitoring in cell manufacturing, which can alleviate the negative effect of the intrinsic
patient-to-patient variability.
There are two reasons why a new statistical method is needed for monitoring critical
quality attributes (exampled by the cell concentration) in cell manufacturing. Firstly, a direct
measurement method for cell concentrations is not suitable in cell manufacturing (Slouka
et al., 2016). Such a method typically requires experienced technicians to collect culture
media, take microscopic images, and perform computation via an image-based software
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Figure 1: An illustration of the four steps in a typical CAR T cell therapy. This work focuses
on the cell culturing (or cell manufacturing) step, i.e., step 3.
(e.g., ImageJ, see Collins, 2007). Therefore, it is labor-intensive, time-consuming, and
may introduce contamination to the culture media. Furthermore, the direct measurement
method is oftentimes destructive – the collected cells would be killed for taking microscopic
images. Secondly, while there are non-destructive sensors available, these sensors need to
be calibrated due to the unknown parameters in the sensing relationship (Pan et al., 2019).
For example, impedance sensors (adopted in this work, see Figure 2), which measure the
dielectric relaxation of cell suspension, can be used to effectively estimate cell concentrations
after the calibration of unknown electrical attributes, e.g., permittivity (Gheorghiu and
Asami, 1998) and resistivity (Goh and Ram, 2010). However, due to the patient-to-patient
variability, those electrical attributes not only are unknown but also vary among different
patients, leading to difficulties in recovering cell concentrations from sensor readings.
We introduce in this work a calibration-free statistical method for online monitoring
in cell manufacturing. Specifically, the intrinsic patient-to-patient variability is modeled
by a patient-specific calibration parameter. We propose to use multiple sensor readings to
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construct a patient-invariance statistic, where a transformation is adopted to isolate and
alleviate the effect of the calibration parameter. The constructed invariance statistic is then
used to model the critical quality attribute of interest. In the training stage, we use the
historical data to estimate a transformation and model parameters via a carefully formulated
optimization problem, rather than estimate the calibration parameter as in the standard
calibration problem (Kennedy and O’Hagan, 2001; Tuo and Wu, 2015). In the monitoring
stage, we use the online sensor readings to recover the underlying critical quality attribute
through the patient-invariance statistic, free from the calibration parameter. We demonstrate
improvements of the proposed calibration-free method in both simulation experiments and
a real-world case study of monitoring viable cell concentrations in cell manufacturing. The
proposed approach provides an effective way to monitor cell manufacturing, and therefore,
reduces the cost for the promising CAR T cell therapy in treating cancers.
The remaining part of the article is organized as follows. In Section 2, we formulate the
biosensing problem in cell manufacturing, with an emphasis on its challenging aspects. In
Section 3, we present the proposed calibration-free method. A detailed simulation study and
a real-world cell manufacturing case study are conducted in Sections 4 and 5, respectively.
We conclude this work with future directions in Section 6.
2 Biosensing in cell manufacturing
We first describe the biosensing problem of recovering the Viable Cell Concentration (VCC)
in cell manufacturing. We then discuss the key challenge – the patient-to-patient variability,
and related works.
2.1 Impedance-based biosensing
As discussed in Section 1, the goal is to monitor VCC in cell manufacturing, thereby reducing
the cost of the CAR T cell therapy. One state-of-the-art approach is to use biosensors to
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Figure 2: An illustration of the adopted impedance-based biosensors in the cell manufacturing
application: (a) shows a photo of the biosensor design and (b) shows the biosensing setup.
measure impedance signals, as indicators for the VCC of interest (Gheorghiu and Asami,
1998; Pan et al., 2019). As illustrated in Figure 2, we adopt impedance-based biosensors
with a facing-electrode (FE) design (Miura and Uno, 2019): Our FE biosensor consists of
a pair of parallel-plate electrodes and silicone at four corners to maintain a gap between
them; it would be soaked in media to monitor floating cells in between the electrodes.
With the adopted biosensors, we need a biosensing method to recover VCCs from
impedance readings. From physical knowledge, we know that the impedance reading
between the two electrodes reflects the cell amount due to the capacitive property of viable
cell membranes (Schwan, 1957). The sensing relationship is denoted by
y = f(x, θ, η), (1)
where y is the impedance reading, x is the underlying VCC of interest, θ denotes the
sensor geometry, e.g., the gap width, and η models the underlying electrical attributes, e.g.,
permittivity and resistivity. Here, the relationship f(·) is unknown due to the dynamic
interaction between cells and biosensors, and extremely challenging to simulate via computer
codes considering the micro size of cells. In the proposed calibration-free method, we first
learn the sensing relationship f(·) from the historical data of different patients (i.e., the
“training” stage), and then conduct online inference of the VCC using the impedance readings
for new patients (i.e., the “monitoring” stage).
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Methods f(·) Online η∗ Historical ηj
Inverse problem (Aster et al., 2018) Known Unknown N.A.
Supervised learning (Bishop, 2006) Unknown Same Same
Calibration (Kennedy and O’Hagan, 2001) Unknown Unknown Known
Calibration-free (proposed) Unknown Unknown Unknown
Table 1: A comparison of the application scenarios of the proposed calibration-free method and
other standard methods in the literature.
2.2 Patient-to-patient variability
The key challenge in biosensing is that the electrical attributes η are unknown in both
training and monitoring and different for each patient (also see an illustrating gravity
application in Section 4.1). Note that it is impractical to compute η for a patient from first
principle since it represents the intrinsic properties from genetic material of the patient.
One popular way is to model η as a calibration parameter, and estimate it from the training
dataset {yj, xj, θ}Jj=1. Existing approaches include Bayesian implementation (Kennedy
and O’Hagan, 2001), maximal likelihood estimation (Joseph and Melkote, 2009), and an
interpretative l2 optimization (Tuo and Wu, 2015). However, such methods are proposed
specifically for data fusion of computer experiments and physical experiments, where η is
available in the former and a constant in the latter. Whereas in biosensing, there is no
effective computer simulator, and electrical attributes η vary among physical experimental
runs for different patients. In the literature, this challenge is also related to the functional
calibration problem (Plumlee et al., 2016; Brown and Atamturktur, 2018; Ezzat et al., 2018),
where the calibration parameter η = η(x) is modeled as a function of the input variables.
In the biosensing application, however, the calibration parameter η varies among different
patients yet is a constant over different input VCCs for each patient.
The biosensing problem is also related to the inverse problem in the literature (Aster
et al., 2018), where one would estimate both x and η via an optimization problem. However,
such a method typically assumes that the sensing relationship f(·) is known or can be
easily learned with a complete data {yj, xj, θ, ηj}nj=1, whereas, the calibration parameter
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η is unknown even in the training stage in biosensing. Furthermore, one may regard η as
an additional model parameter in the unknown relationship f(·), and adopt a standard
supervised learning scheme (Bishop, 2006) for finding both f(·) and η; this implicitly
assumes that η is a constant for different patients, which is not true in biosensing. Table
1 summarizes the related methods discussed; with extensive efforts in literature search,
we have not found a standard method, which can be directly adopted for the biosensing
problem in cell manufacturing.
3 Calibration-free biosensing method
We present the proposed calibration-free method in four parts. First, we discuss the sensing
relationship for multiple sensors. We then introduce an invariance statistic to alleviate
patient-to-patient variability. In the online monitoring stage, we use the invariance statistic
to recover VCCs. In the training stage, we propose a carefully constructed optimization
problem and an algorithmic framework to estimate the underlying sensing model.
3.1 Sensing relationship with multiple sensors
The key idea of the calibration-free method is to use multiple sensors to address the unknown
and patient-specific calibration parameter. For the i-th sensor, we let θi be its geometry
parameter. Consider first the sensing relationship for a given patient (or experiment).
Denote yi[t] as the scalar impedance reading (more details in Section 5) from the i-th
sensor at experimental time t. Following (1), we model yi[t] = f(x[t], θi, η) via the sensing
relationship f(·) : R3 7→ R. Here, x[t] is the VCC at experimental time t, and η is the
calibration parameter. It is important to note that measurements from different sensors
{y1[t], y2[t], · · · } can be modeled by a same calibration parameter η, featuring the underlying
values for electrical attributes of the specific patient’s cells. This patient-specific property is
the key to “canceling out” the calibration parameter using multiple sensor readings (see
7
Section 3.2).
We then introduce an additional superscript j for different patients:
yji [t] = f(x
j[t], θi, η
j), i = 1, 2, · · · , I, t = 1, · · ·T, and, j = 1, · · · , J. (2)
Equation (2) further layouts our biosensing settings with multiple sensors: (i) We assume
the homogeneity of VCC, i.e., at given time t and a given patient j, the VCC xj[t] is
the same for different senors θi at different locations (see Figure 2 (b)). This is because,
in suspension cell manufacturing, the culture media is constantly stirred to ensure the
homogeneity of nutrition, and thereby VCC (Haycock, 2011). (ii) We use the same set of
sensors with known parameters {θi}Ii=1 for all J patients and at different experimental time
t. Those parameters are known from the fabrication process or can be easily measured from
the sensors. Note that the proposed method is also effective for different sets of sensors,
as long as those sensor parameters are known – the same sensor assumption is only for
fabrication convenience and notation simplicity. (iii) Besides for different sensors θi, the
calibration parameter ηj is the same among different measurement time t. This is because
ηj models the intrinsic property of the j-th patient’s cells, which typically does not change
during cell manufacturing. After we clearly layout the above settings, we can then construct
the patient-invariance statistic and recover the underlying VCC.
3.2 Invariance statistic
For notation simplicity, we drop the experimental time [t] and write θi in the subscript in
this subsection. Furthermore, we rewrite (2) by decomposing f(·) into two parts:
yji = fθi(x
j, ηj) = µi(x
j) + δi(x
j, ηj). (3)
Here, for a given sensor θi, µi(·) : R 7→ R models the part of effect of VCC x on impedance
reading y, without hampered by the patient-specific calibration parameter η; and δi(·) :
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R2 7→ R is the remaining effect of both x and η on y. Intuitively speaking, µi(·) can be viewed
as the mean process of f(·) by plugging in some population average of {ηj}Jj=1, ignoring
the patient-to-patient variability; it can also be interpreted as the physical understanding
of the sensing relationship. In practice, the mean relationship µi(·) is oftentimes known,
at least to a certain degree, prior to experimentation according to the domain-specific
knowledge (e.g., the known set of basis functions, see Section 5). On the other hand, δi(·) is
the variability term, i.e., how patient-to-patient variability affects the impedance reading.
Such a term leads to different readings, even when the VCC x is the same. Note that in one
of the considered baseline methods (see Sections 4 and 5), we ignore δi(·), i.e., assuming the
calibration parameter is a constant; this will lead to noticeable errors when estimating x.
This variability term δi(·) is typically unknown. Such a decomposition of a mean trend and
a variability term is widely assumed in different modeling methods (see, e.g., Guillas et al.,
2018; Chen et al., 2019).
Assume for now δi(x, η) = δi(η), which suggests that the mean relationship µi(·) extracts
all the dependency of x on y (further discussion in Section 3.4). In other words, fi(x, η) is
assumed to be separable for each sensor θi:
yji = µi(x
j) + δi(η
j). (4)
Now, we construct a statistic F which is invariant to the calibration parameter η. To
gain intuition, consider the following illustrating example with known δi(η) = θiη for
i = 1, 2 (see the illustration application in Section 4.1). If we take a log-transformation to
the variability term log δi(η
j) = log θi + log η
j, the effect of the calibration parameter ηj
is further separated from θi. Therefore, by subtracting the (log-transformed) variability
at different sensors, one can obtain an invariance statistic F = log δ1(η
j) − log δ2(ηj) =
log θ1 + log η
j − (log θ2 + log ηj) = log(θ1)− log(θ2). Note that we incorporate the patient-
specific property of the calibration parameter when constructing the invariance statistic.
Following the above intuition yet with the unknown variability term δi(·), we construct
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the following statistic, via a linear combination of the transformed δi(·):
F (ηj) =
I∑
i=1
ciF [δi(ηj)] =
I∑
i=1
ciF [yji − µi(xj)], (5)
for patient j with ηj . Here, c1, · · · , cI are pre-defined combination coefficients, and
∑
i ci = 0.
With a properly selected transformation F [·] : R 7→ R, (5) gives the target invariance
statistic F = F (ηj). Note that here we adapt a general transformation F [·], instead of the
specific log-transformation in the above example. The transformation F [·] would be selected
so that the dependency of the invariance statistic F to ηj is minimal; a detail estimation
method for F [·] will be discussed in Section 3.4.
It is important to note that we reconstruct the sensing model from (2) to (5) via the
proposed invariance statistic. This is again due to the key challenge of patient-to-patient
variability. Consider first using (2) for VCC recovery (also see the discussion in Section
2.2). Due to the unknown and patient-specific calibration parameter ηj, it is challenging
to either learn a sensing model from training data or recover VCCs for a new patient.
However, the new model (5) contains only the invariance statistic, and is free from the
calibration parameter. Thanks to the properly selected transformation and the combination
(see Section 3.4), the invariance statistic would be approximately a constant for different
patients. Therefore, our new model (5) allows an effective estimation of the sensing
relationship (only the mean part needed) similar to the standard calibration problem with
a constant calibration parameter (Tuo and Wu, 2015), and then a calibration-free recovery
of the VCC of interest.
3.3 Online calibration-free recovery
We present next the method for recovering the VCC of interest x∗, in the online monitoring
stage for a new patient denoted by ∗. At any time t, the sensor reading is denoted as
Dmonitor = {y∗i , θi}Ii=1 along with the unknown calibration parameter η∗. Assume for now
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the mean sensing relationship µi(·) and the transformation F [·] are known (see Section 3.4
for the estimation). We adopt the new sensing model (5) with the invariance statistic
F (η∗) =
I∑
i=1
ciF [y∗i − µi(x∗)] , (6)
where x∗ is the target VCC. Note that the computed F (η∗) in online monitoring is also
invariant to the calibration parameter η∗. Therefore, the VCC of interest x∗ can be recovered
by minimizing the squared difference between the computed value and the underlying value
F¯ (see Section 3.4 for the estimation):
xˆ∗ = argmin
x∗
(
I∑
i=1
ciF [y∗i − µi(x∗)]− F¯
)2
. (7)
In the cell manufacturing application, we are interested in recovering a VCC curve xˆ∗[t]
over the whole manufacturing period t = 1, · · · , T . To this end, we perform optimization
(7) for T times corresponding to each experimental time t. Note that here we have not
incorporated the time-dependency (or smoothness) of the recovered function xˆ∗[t] in online
recovering; one can use postprocessing methods or directly model x∗[t] via a parametric
form in the optimization (7). Readers are referred to functional data analysis literature
(Ramsay, 2004; Wang et al., 2016) for more discussion.
3.4 Parameter estimation
We estimate the unknown transformation F [·], and the physical relationship µi(·) using
the training data Dtrain = {yji [t], xj[t], θi}Tt=1
J
j=1 at hand. In our implementation, the
transformation F [·] is paramterized by the Box-Cox transformation (Box and Cox, 1964;
Sakia, 1992)
Fλ[z] =
log(z) if λ = 0(zλ−1)
λ
if λ 6= 0
. (8)
11
Note that the log-transformation in the above example is a special case in the Box-Cox
transformation. Here, the Box-Cox transformation contains an unknown parameter λ. A
two-parameter BoxCox or YeoJohnson transformation (Yeo and Johnson, 2000) can also be
used if the data are not restricted to be nonnegative. Furthermore, in this article, we will
focus on the parametric transformation (8), but our proposed method are general and can
be applied to non-parametric cases.
As for the physical relationship µi(·), we adopt the following basis decomposition:
µi,β(x) = µβ(x, θi) =
K∑
k=1
βkφk(x, θi). (9)
Here, φk(·); k = 1, 2, · · · , K are the pre-defined basis functions and β = [β1, · · · , βK ]T
denotes the vector of corresponding coefficients. Such a set of basis {φk(·)}Kk=1 is selected
by the physical knowledge of the cell manufacturing system or the observation from data.
Meanwhile, to account for the separable assumption δi(x, η) ≈ δi(η) in Section 3.2, we
introduce slack variables ∆ = {∆ji}Ii=1
J
j=1 to account for the “goodness” of the assumption
(more discussion below). Furthermore, the underlying value for the best invariance statistic
F¯ is also unknown and need to be estimated from data (see Section 3.3).
We propose to estimate the unknown parameters {λ,β, F¯ ,∆} via the following opti-
mization problem with two penalization terms:
min
λ,β,F¯ ,∆
lα(λ,β, F¯ ,∆) = min
λ,β,F¯ ,∆
∑
t,j
[
I∑
i=1
ciFλ[yji [t]− µβ(xj[t], θi)]− F¯
]2
+ α1
∑
i,j,t
[|yji [t]− µβ(xj[t], θi)|1 −∆ji ]2 + α2|β|1. (10)
Here, α1 and α2 are two penalization coefficients, and | · |1 denotes the vector l1 norm.
The main objective term (i.e., the first term) in (10) is for achieving the best patient-
invariance property of the constructed statistic F . Specifically, we minimize the mean-
squared error (MSE) of its underlying truth F¯ and the computed value from data. This is
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equivalent to modeling the patient-invariance statistic F j for each patient as i.i.d. random
draws from a normal distribution N (F¯ , σ2) with mean F¯ and variance σ2. Moreover, the
first penalization term in (10) is for the separable assumption δi(x, η) ≈ δi(η). Here, we
minimize the corresponding MSE of the set {δi(xj[t], ηj)}Tt=1 to the underlying truth ∆ji ,
for each sensor i and patient j. Similarly, this can also be viewed as modeling δi(·, ηj) via
i.i.d. normal random variables; the corresponding penalization α1 can then be interpreted
as the ratio between the variances of the two normal distributions. Finally, the second
penalization term α2|β|1 is for basis selection, similar to the widely used LASSO method in
the literature (Tibshirani, 1996; Donoho, 2006). This is because, in the cell manufacturing
application, one would only have an intuitive understanding of the sensing relationship; we
will collect a set of basis functions from experience and select the suitable ones via this
penalization.
From the duality of the optimization problem, (10) can also be viewed as unpenalized
log-likelihood combining both normal random variables with a sparsity constraint ‖β‖1 ≤ γ
(Boyd and Vandenberghe, 2004). The parameter α1 sets the variance ratio between the
two random variables, and α2 controls the desired sparsity level as parameter γ. Since the
objective is to obtain a high recovery accuracy of the VCC of interest, α1 and α2 would be
tuned using cross-validation techniques (Friedman et al., 2001).
Consider now estimating the parameters {λ,β, F¯ ,∆} via optimization (10) for fixed
α1 > 0 and α2 > 0. We propose to use the following Blockwise Coordinate Descent (BCD)
optimization algorithm, described below. First, assign initial values for {λ,β, F¯ ,∆}. Next,
iterate the following three steps until the convergence is achieved: (i) for fixed λ and β,
update {F¯ ,∆} via the following estimates from first-order conditions
ˆ¯F =
1
JT
∑
i,j,t
ciFλ
[
yji [t]− µβ(xj[t], θi)
]
, ∆ˆji =
1
T
T∑
t=1
|yji [t]− µβ(xj[t], θi)|1; (11)
(ii) for fixed β and F¯ , update the transformation parameter λ ignoring the two penalization
terms; and (iii) for fixed λ, F¯ and ∆, optimize for β via numerical line search methods, e.g.,
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Algorithm 1 The BCD algorithm for parameter estimation (10)
1: • Set initial values λ← 0 and β ← 1K
2: • Set I × J × T ×K tensor Φ with each element Φijtk ← φk(xj [t], θi)
3: repeat
4: Optimizing F and ∆:
5: • Set I × J × T tensor D with each element Dijt ← yji [t]−
∑
k Φijtkβk
6: • Update F¯ ←∑ijt ciFλ[Dijt]/J/T
7: • Update ∆ji ←
∑
t |ciFλ[Dijt|1/T for i = 1, · · · I and j = 1, · · · J
8: Optimizing λ:
9: • Set l0(λ,β, F¯ ,∆)← lα(λ,β, F¯ ,∆) with α1 = α2 = 0
10: • Update λ← argminλ lα(λ,β, F¯ ,∆)
11: Optimizing β:
12: • Update β ← argminβ lα(λ,β, F¯ ,∆) with the L-BFGS method
13: until λ, F¯ , ∆ and β converge
14: • return λ, F¯ , ∆ and β
L-BFGS algorithm (Liu and Nocedal, 1989). The full optimization procedure is provided
in Algorithm 1. Since (10) is a non-convex optimization problem, the proposed BCD
algorithm only converges to a stationary solution (Tseng, 2001). Because of this, we suggest
performing multiple runs of Algorithm 1 with random initializations for each run, then
taking the converged estimates for the run with smallest objective function. These runs
should be performed in parallel if possible, to take advantage of the parallel computing
capabilities in many computing systems.
It is important to note the difference between the training stage in our calibration-
free method and the calibration stage in the standard calibration problem (Kennedy and
O’Hagan, 2001). In calibration methods, the calibration parameter η, assumed to be a
constant, is directly estimated from the training set. This can be viewed as estimating a
population average of the historical {ηj}Jj=1, which would not be helpful in our cell manu-
facturing application. Due to the patient-to-patient variability, the calibration parameter
η∗ corresponding to the new patient can be completely different from the historical average
value. In contrast, our calibration-free method adopts a patient-invariance statistic F ,
constructed from multiple sensor readings, to alleviate this patient-to-patient variability. In
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our training setup, we learn the unknown mean relationship µi(·) and the transformation
F [·], which provide the best patient-invariance statistic F . We can then use the invariance
statistic F to effectively recover VCCs via (7), free from the patient-specific calibration
parameter η∗.
4 Simulation study
A detailed simulation study is conducted in this section. We first look into a toy application
of recovering gravitational acceleration coefficients, to show the applicability of the proposed
method. We then discuss more simulation experiments with different sensing relationships.
4.1 A gravity application
Consider the following toy application, where the goal is to recover the gravitational
acceleration coefficient x, for a different planet. As illustrated in Figure 3, we drop a ball
and measure the traveling distance y of the ball after a certain period of time θ. From the
physical knowledge, we have the relationship
y = f(x, θ, η) =
1
2
xθ2 + ηθ. (12)
Here, y is the traveling distance measured by, e.g., taking a photo, η is the initial velocity of
the ball, and θ is the time period between dropping the ball and taking the photo. Suppose
the ball is dropped by an engineer, meaning that the initial velocity η is non-zero and
changes among different drops. With the collected data {y, θ}, typically, one cannot recover
the gravitational acceleration x even with the known relationship (12). This is because the
initial velocity η is also unknown. The key idea of the proposed calibration-free method is
to take multiple photos at different time θi; i = 1, · · · , I. Therefore, more data {yi, θi}Ii=1 is
collected with the same initial velocity η. We can then use the proposed invariance statistic
and Algorithm 1 to “cancel out” η and conduct inference on the gravitational acceleration
15
Figure 3: An illustration and notations of the toy application of recovering the gravitational
acceleration coefficient.
x of interest.
The setup for recovering the gravity coefficient is as follows. We set the number of
photos I = 3, with parameters (i.e., the time of taking photos) {θi}3i=1 = {0.5, 1, 1.5}. A
historical dataset {yji , xj; ηj}Jj=1 of size J = 100 is generated with calibration parameters
(i.e., initial speed, unknown) ηj ∼ Unif(1, 3), gravity coefficients xj ∼ N (9.8, 12), and
each sensor reading (i.e., traveling distance) yji simulated by (12) with an additional i.i.d.
measurement error following N (0, 0.42). To test the recovery accuracy, we let the underlying
truth x∗ = 9.8, η∗ ∼ Unif(1, 3) randomly generated, and y∗ obtained by (12) with the same
measurement error.
The proposed calibration-free method (via Algorithm 1) is applied to find the best
transformation Fλˆ[·] and then recover the gravitational acceleration xˆ∗. The linear com-
bination coefficients are {ci}3i=1 = {1, 1,−2}, and the set of candidate basis functions is
Φ = {x, θ, θx, θx2, θ2x}. The proposed calibration-free method is repeated, with newly
generated test data {y∗, x∗ = 9.8; η∗}, for 20 times.
We consider the following two baseline methods (also see Table 1). First, we implement
the supervised learning setting (Bishop, 2006), i.e., assuming the calibration parameter
η = ηj = η∗ is the same in both training stage and monitoring stage. Such an assumption
is not true in the considered cell manufacturing application. Specifically, we use the
historical dataset {yji , xj}100j=1 to estimate an η¯ and a relationship g(x, θ) := f(x, θ; η¯), which
16
Figure 4: Results of the gravity application: (a) shows the recovered gravitational acceleration
by the three considered methods. The red line marks the underlying truth x∗ = 9.8. (b) shows the
boxplots of absolute error ratios between the proposed method and baseline baseline methods. The
red line marks the ratio of 1.0.
would then be used to recover xˆ∗. Here, we use the same set of basis functions Φ for g(·),
and a similar optimization scheme with LASSO type penalization (Tibshirani, 1996) for
estimating the coefficients β. This method is referred to as “SameCal”. The other baseline
method is the standard l2 calibration method suggested by Tuo and Wu (2015). In order
to adopt this method, we need to assume that the calibration parameters {ηj}100j=1 in the
historical data are known, which is not true in reality. Therefore, we refer this method
as “Oracle”. To estimate the sensing relationship f(·), we adopt the set of basis functions
Φo = {x, θ, θx, θx2, θ2x, ηx, ηθ, ηxθ} and a similar optimization scheme with LASSO type
penalization. Both baseline methods are implemented to recover x∗ of interest via minimizing
the squared difference similar to (7), using the same 20 simulated test data.
Figure 4 (a) shows the boxplots of the estimated xˆ∗ using the proposed calibration-free
method and the two baseline methods. The red line indicates the ground truth value
x∗ = 9.8. Among the three methods, the Oracle baseline preforms the best since it queries
additional information of the calibration parameter in the training stage, which is again not
feasible in reality. We notice that the proposed calibration-free method performs almost
as good as Oracle. It can accurately recover the true value, with the mean over the 20
estimates 9.7 and a relatively small variance, whereas for the SameCal baseline, the mean
for 20 estimates is 10.8 and a noticeable bigger variance is observed.
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We also conduct a pairwise comparison over the 20 test repetitions. Figure 4 (b) shows
the boxplots of absolute error ratios of the proposed method over the two baseline methods,
with the red line indicating the ratio of 1.0. We notice that the proposed method is only
slightly worse than Oracle; this is impressive since our method do not query the underlying
calibration parameter in the training stage. Furthermore, the proposed calibration-free
method is noticeably better in recovering the true x∗ compared to SameCal. More specifically,
our method outperforms SameCal with smaller errors in 17 estimates over 20 test runs in
total. This is not surprising since the calibration-free method, utilizing the patient-invariance
statistic, can address the patient-specific calibration parameters η∗.
4.2 More experiments
Here, we conduct more experiments on the proposed calibration-free method. Specifically,
we consider the following four underlying sensing relationships fk(x, θ, η):
1. f1(x, θ, η) = xθ + ηθ
2;
2. f2(x, θ, η) = 3x+ 2θx+ xθη;
3. f3(x, θ, η) = θx+ x
2 + θη2 +
√
θη2 +
√
xη/4;
4. f4(x, θ, η) = sin(x) + (x+ η)
θ + x
θ+η
.
Note that function f1(·) is quite similar to the sensing relationship (12) in the gravity
application in Section 4.1. For functions f2(·) and f3(·), we notice the existence of interaction
terms between x and η, which means the separable assumption δi(x, η) = δi(η) in Section
3.2 does not hold. However, f2(·) and f3(·) can still be approximately represented by the
adopted set of basis functions Φ. For function f4(·), it is quite complex, and cannot be
represented by Φ. We test all four functions, using the proposed calibration-free method
and the same two baseline methods – SameCal and Oracle – introduced in Section 4.1. The
detailed test procedure is the same as that in Section 4.1.
18
Figure 5: Boxplots of error ratios between the proposed method and the considered baselines,
under different sensing relationships. The red line marks the ratio of 1.0, indicating the baseline
method achieves the same accuracy as the proposed method.
Figure 5 shows the boxplots of the absolute error ratios of the proposed method over the
baseline SameCal method (a) and the baseline Oracle method (b), under all four underlying
sensing functions fk(x, θ, η); k = 1, · · · , 4. We notice the error ratios in Figure 5 (a) are
mostly smaller than 1.0, indicting that the proposed method can achieve smaller errors
compared to SameCal. This is because the assumption of constant calibration parameter in
SameCal does not hold in cell manufacturing application (and thereby in this simulation
study), whereas, our calibration-free method can address the patient-specific calibration
parameter via a proper combination of multiple sensor readings. Moreover, compared to
Oracle, the proposed method is only slightly worse. This shows the good performance of our
calibration-free method: Though we do not know the values of the calibration parameter,
we can recover the underlying parameter of interest similar to the Oracle baseline, where
whose values are assumed accessible. Finally, we notice that for the sensing relationship
f4(·), while the proposed method adopts an inappropriate basis decomposition Φ, it still
outperforms SameCal. This is again because the proposed calibration-free method introduces
the invariance statistic to alleviate the effect of patient-to-patient variability, and therefore,
shows improved performances in recovering the quantity of interest.
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Figure 6: The cell manufacturing application: (a) an illustration and (b) the actual experimental
setup with an emphasis on the impedance measurement part.
5 Cell manufacturing case study
In this section, we apply the proposed calibration-free method to the motivating case study
of cell manufacturing. As discussed in Sections 1 and 2, we are interested in recovering and
monitoring the Viable Cell Concentration (VCC) x[t] at different experimental time t. This
is because the goal of cell manufacturing is to culture a small batch of cells to a significant
amount, for an effective re-administering in the CAR T cell therapy (see Figure 1).
5.1 Experimental setup
In our experiment, human leukemic T cells (Jurkat E6-1; American Type Culture Col-
lection, ATCC®) are cultured in ATCC-formulated culture medium (RPMI-1640; GE
Healthcare) with 10% fetal bovine serum, 2 mM L-glutamine, 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 1 mM sodium pyruvate, 4500 mg/L glucose, and
1500 mg/L sodium bicarbonate in a 75 cm2 petri dish (Nunc™ EasYFlask™; ThermoFisher
Scientific™). The cells are cultured in a humidified incubator controlled at 37°C and 5%
CO2, and the culture media is pre-heated to avoid the temperature effect on the impedance
measurement (Dlugolecki et al., 2010).
The impedance measurements are obtained by our electric cell-substrate impedance
sensing. Figure 6 illustrates the experimental setting for the impedance measurement. Here,
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we use I = 4 sandwich shape 3D impedance sensors, consisting a pair of parallel-plate
electrodes and PDMS (Sylgard 184, Tow Corning) to maintain a gap between two electrodes
(see Figure 2 (b)). In our experimental setup, the geometry parameter θ of the sensors is the
edge length of the electrode pads, and {θi}4i=1 = {8mm, 10mm, 12mm, 14mm}. Impedance
measurements are conducted by an LCR meter (E4980AL; Keysight Technologies) with
a sinusoidal signal of 22 mVrms under multiple frequencies ranging from 500 Hz to 100
kHz. We let impedance measurement y be the relaxation strength computed from the
raw impedance readings over frequencies, i.e., the difference between permittivity values
of high-frequency end and low-frequency end of the dielectric relaxation process, for its
high dependency to the VCC of interest (Schwan, 1957). The measurement is taken every
15 minutes for around 30-35 hours. This is because typically after 35 hours, we have to
change the culture media and expand the cells to a bigger cell culture flask, which would
inevitably interrupt the online monitoring. This results in an online monitoring dataset
Dmonitor = {yji [t], θ}Tt=1
J
j=1 with the underlying VCCs to be recovered.
The ground truth VCCs are obtained by an automated cell counter (TC20™; Bio-Rad
Laboratories, Inc.), and the concentration is maintained between 1 105 and 1 106 cells/mL.
Multiple repetitions are performed, with the averaged value reported as the underlying
VCC x. Note that the measurement procedure is not only labor-intensive but may also
introduce contamination to the culture media (see Section 1). We will only measure VCC
around six times per cell culture experiment, which leads to a much smaller (τ  T ) yet
full training dataset Dtrain = {yji [t], xj[t], θ}τt=1
J
j=1.
We conduct the cell culturing for J = 5 experiments, each with different starting
materials, i.e., different calibration parameters ηj . We use the same I = 4 sensors {θi}4i=1 =
{8mm, 10mm, 12mm, 14mm} for the J = 5 experiments. In experiment j, we measure and
compute the relaxation strength of impedance yji [t] for each sensor i, at different time t
(every 15 minutes, T ≈ 130 in total). Meanwhile, we measure the ground truth VCC xj[t]
with a much lower resolution (τ ≈ 6 in total).
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Exp 1 Exp 2 Exp 3 Exp 4 Exp 5 Mean
Proposed 0.092 0.270 0.080 0.379 0.590 0.282
SameCal 0.500 0.174 0.328 0.742 0.760 0.501
Table 2: Cross-validation errors of the recovered VCCs for the cell manufacturing case study,
using the proposed calibration-free method and the baseline SameCal method.
5.2 Cross validation of viable cell concentration
For the collected training dataset Dtrain, we first preform a cross-validation test (Friedman
et al., 2001) on the recovered VCCs. More specifically, we apply the proposed calibration-
free method (via Algorithm 1) to learn the sensing relationship using four out of five
experiments, and then recover VCC xˆj[t] for the remaining experiment via (7). We let
the linear combination coefficients {ci}4i=1 = {1,−1, 1,−1} and select the same set of basis
functions Φ as in Section 4.1. Furthermore, a log-transformation on VCCs is performed prior
to the analysis. We consider SameCal (see Section 4) as the baseline method. Such a method
introduces an additional assumption that the calibration parameter is a constant. Note
that the Oracle baseline cannot be adopted here since the actual values of the calibration
parameter are always unknown, which is the key motivation of the proposed calibration-free
method (also see Section 2.2 and Table 1).
Table 2 shows the absolute errors of the recovered log VCCs when the ground truth
VCCs are measured in each experiment. We observe that the proposed method outperforms
the baseline SameCal method four experiments out of five. Furthermore, the mean error of
the five experiments by the proposed method is 0.282, which is almost two times smaller
than that of 0.501 by SameCal. This is due to the fact that the calibration parameter, which
models the patient-to-patient variability, is not a constant in cell manufacturing (Hinrichs
and Restifo, 2013); the proposed calibration-free method properly addresses this variability
via the construction of the patient-invariance statistic.
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Figure 7: The recovered VCC over time of two cell manufacturing experiments under the two
considered methods. The ground truth VCC measurements are shown in dots.
5.3 Online recovery of viable cell concentration
We then perform VCC recovery on the online monitoring set Dmonitor. Here, the sensing
relationship is estimated using all five experiments in the training set Dtrain. Figure 7
shows the two recovered log VCC curves over the whole culture time log xˆj[t], via the
proposed calibration-free method (in red line) and the baseline SameCal method (in green
dash line). The ground truth (log) VCC measurements in Dtrain are also plotted in black
dots. We see that the proposed method recovers a meaningful estimation of VCC. The
recovered log xˆj[t] increases approximately linear over the culture time t, indicating xˆj[t]
growths exponentially in time; this matches the preliminary understanding in the cell culture
literature (Haycock, 2011). Furthermore, the recovered xˆj[t] approximately passes through
the ground truth measurements. However, due to the huge patient-to-patient variability, the
baseline SameCal method struggles in either passing through the ground truth experiments
or providing reasonable estimates of VCC curves. Our calibration-free method, adopting
the patient-invariance statistic, appears to alleviate such variability well.
The proposed calibration-free method can also provide important biological insights for
cell growth in cell manufacturing. From Figure 7 (b), we notice a decrease in the VCC curve
at around hour 32. This may be due to the lack of nutrition in the media since the culture
media typically needs to be changed after 30 hours. Furthermore, we observe from Figure 7
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that the VCC curves decrease slightly in the first two hours in cell manufacturing. This
may be because of the lack of viability of the cells at the beginning of the culture process –
though we have already thaw cells and stood them still for several minutes, it seems that a
certain portion of cells still do not gain full viability and die soon. As a result, we suggest
standing the cell still longer for future experiments. Last but not least, we notice a small
VCC decrease when conducting the ground truth VCC measurements. One reason for this
is that the measurement itself is not in-line and needs to contact the culture media; it may
introduce contamination, and therefore, kill a small portion of cells (Haycock, 2011). In
contrast, the proposed calibration-free biosensing method, together with impedance-based
biosensors, provides an in-line, non-destructive, and non-contact way for VCC monitoring
in cell manufacturing.
6 Conclusion
In this work, we propose a new calibration-free method for monitoring viable cell con-
centration in cell manufacturing, which is a critical component in the promising CAR
T cell therapy. The key challenge here is the patient-to-patient variability in the initial
culturing material, leading to poor performances in recovering viable cell concentrations via
existing methods. We propose to use multiple impedance-based biosensors with different
geometries and an associated calibration-free statistical framework for online recovery of
viable cell concentrations. Specifically, we model the patient-to-patient variability via a
patient-specific calibration parameter. We then construct a patient-invariance statistic,
which uses a transformation and a linear combination of sensor readings to alleviate the
effect of the calibration parameter. In the training stage, we learn the best transformation
and the sensing relationship via a carefully formulated optimization problem. In the online
monitoring stage, viable cell concentrations can be recovered via the invariance statistic, free
from the patient-specific calibration parameter. We then apply the proposed calibration-free
method in different simulation experiments and a real-world case study of cell manufacturing,
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where the proposed method demonstrates substantial improvements against the existing
methods. Therefore, we believe the proposed calibration-free method can play an essential
role in cell manufacturing and reduce the cost of the promising CAR T cell therapy.
Looking ahead, there are several interesting directions for future exploration. To begin
with, a more thorough analysis of impedance-based sensors can be conducted, with a detailed
comparison of sensitivity using different experimental settings such as sensor geometries and
electrode materials. Moreover, we adopt in this work a parametric sensing relationship and
a heuristic approach for parameter estimation. This is mainly due to the already improved
performance compared to the baseline methods. A more flexible, and non-parametric
Gaussian process regression method (Santner et al., 2013; Lin and Joseph, 2019) with a
rigorous likelihood-based parameter estimation scheme may lead to further improvements
in recovering viable cell concentrations, as well as other critical quality attributes. Finally,
micro cameras can also be used in cell manufacturing. Therefore, we are also interested
in monitoring cell manufacturing based on cell morphology. In this case, physics-informed
deep learning frameworks in the literature (Raissi et al., 2017; Chen et al., 2020) appear to
be suitable for recovering critical quality attributes in cell manufacturing.
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